tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
AXGN
AxoGen
Stock Analysis
Analyst Forecasts
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding AXGN?
Track your performance easily
Link Broker

AxoGen (AXGN) Stock News & Sentiment

375 Followers
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
Premium
Company Announcements
AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®
12d ago
8K
AXGN
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
Premium
Press Releases
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
14d ago
AXGN
AxoGen Appoints New CEO and Board Chair for Strategic Renewal
Premium
Company Announcements
AxoGen Appoints New CEO and Board Chair for Strategic Renewal
1M ago
8K
AXGN
AxoGen Updates Corporate Presentation for Stakeholders
Premium
Company Announcements
AxoGen Updates Corporate Presentation for Stakeholders
1M ago
8K
AXGN
Axogen, Inc. Announces New Leadership Appointments
Premium
Press Releases
Axogen, Inc. Announces New Leadership Appointments
1M ago
AXGN
Is AXGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is AXGN a Buy, Before Earnings?
1M ago
AXGN
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
Premium
Press Releases
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
2M ago
AXGN
More AXGN News >

AXGN News on the Web

BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?
Zacks
Bullish
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
Zacks
Neutral
SLNO Skyrockets 800%, BWAY Blasts Past 400% - Were You On Board?
rttnews
Neutral
Axogen Inc (AXGN) Shares Up 2.8% on Sep 17
GuruFocus News
Neutral
Should You Continue to Retain MYGN Stock in Your Portfolio?
Zacks
Neutral
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies
Zacks
Neutral
IINN Stock Gains on Second US Patent Approval for VORTX System
Zacks
Neutral
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Zacks
Neutral

News Score - Last 7 Days

Neutral
AXGN
Sector Average
Media Buzz
This Week10 articles
Weekly Average7.5 articles
News Sentiment
This Week100%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AXGN’s Media Buzz Sentiment?
10 articles about AXGN were published this week. In an average week, 7.5 articles are published.
    What is AXGN’s weekly average amount of articles?
    In an average week, 7.5 articles about AXGN are published.
      What is AXGN’s News Sentiment?
      100% of articles about AXGN were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        EPIXESSA Pharma
        NUVLNuvalent
        INCYIncyte
        BLCOBausch + Lomb Corporation
        ACRVAcrivon Therapeutics, Inc.
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing